Let's talk medical research

It’s no secret that recruiting patients for clinical trials can be a difficult endeavor. And, even when a trial meets its quotas and timelines, many still do not reflect real-world populations. So how can we better engage patients from all walks of life in medical research? 

One in five adults in the U.S. experience a mental health condition each year. Of those, only 43.3% received treatment last year. This World Mental Health Day, we’re highlighting the importance of both awareness and treatment for the millions of people struggling with symptoms.

We’re gearing up to head to Florida later this week for the SCRS Site Solutions Summit, the annual meeting that brings sites, sponsors, CROs, and regulators together to discuss the current state of clinical research and where we go from here. We’re looking forward to meeting some of the brightest in the business, and sharing best practices that can drive success for all. 

Of all of the elements of a clinical trial, optimizing patient recruitment may make the most significant impact on trial timelines. Even if you're meeting your recruitment goals – a rare accomplishment, to say the least – trials and budgets always benefit from better efficiency. 

Ulcerative Colitis (UC) flare-ups can last for days or weeks. Symptoms of a flare may include urgent or frequent bowel movements, diarrhea, blood in stools, and abdominal pain or cramping. Because these symptoms can also be caused by something other than UC, it can sometimes be difficult to tell whether you're experiencing a flare-up. 

Keith Lovell joined Antidote as CFO in September 2015, bringing more than 25 years of financial and commercial experience at companies ranging from major blue chip organizations to startups. Prior to Antidote, he was employee number 30 at Shazam, and helped build it up to a billion dollar valuation. 

The Scrip Awards are where the industry’s best and brightest are recognized for excellence across the drug development spectrum. That’s why we’re absolutely honored to announce that Antidote has been named a Scrip Awards finalist in the category of “Best Technological Development in Clinical Trials.” We’ve been a finalist in this category before, and are thrilled that the evolution of our ...

A few years ago, we wrote a blog series for ACRP in which we focused on patient centricity in clinical trial design, recruitment, and execution. Over the next few months, we’ll be taking a second look at those blog posts, sharing updated versions on our own blog. Here’s an update to the second in that series. 

Clinical research organizations sometimes create surveys and share general statistics about clinical trial participation. But every patient is different, and overarching stats don't tell the full story.

It’s been one year since Laurent Schockmel took the helm at Antidote. We sat down with Laurent to talk about his journey from scientist to CEO and hear his reflections on his first year at Antidote. Here’s what he had to say: